Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24)

The summary for the Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24): The purpose of this Funding Opportunity Announcement (FOA) is to establish one or two centers that can rapidly generate high quality whole genome sequence and variant data from a large number of human specimens representing two types of pediatric conditions - structural birth defects and childhood cancers. The generated data will become a part of a data resource under The Gabriella Miller Kids First Pediatric Research Program, which will allow researchers to investigate the genetic etiology of structural birth defects, and to further elucidate the genetic contribution to childhood cancers.

Federal Grant Title:	Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-RM-16-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.310
CFDA Descriptions:	Trans-NIH Research Support
Current Application Deadline:	Mar 31, 2016
Original Application Deadline:	Mar 31, 2016
Posted Date:	Jan 13, 2016
Creation Date:	Jan 13, 2016
Archive Date:	May 1, 2016
Total Program Funding:	$12,600,000
Maximum Federal Grant Award:	$12,600,000
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Native American tribal governments (Federally recognized)
City or township governments
State governments
County governments
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: See full announcement for complete details.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-16-001.html
Grant Announcement Contact: eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/ Phone 1-866-504-9552
Grants Info

National Institutes of Health 301-496-3405
Similar Government Grants: • Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial No...; • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...; • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional); • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional); • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional); • Using Metabolomics to Investigate Biological Pathways and Networks (R01); • Assay Development for High Throughput Molecular Screening (R21); • Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...